Whereas, the Hb gold standard laboratory measurement (HemoCue®) identified mild anaemia in 8(2.7%), moderate anaemia in 132 (45.2%) and severe anaemia in 152 (52.1%), respectively. This evidence concerns the gene GSTM1 and anemia.